Skip to search.
 FTSE 100 Up 0.42%

More On BIND

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
0.00 0.00(0.00%) N/A
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.88
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.35 - 5.24
Volume:0
Avg Vol (3m):1,204,760
Market Cap:0.00
P/E (ttm):N/A
EPS (ttm):-1.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BIND at this time.

Comparison

Symbol% ChgMkt Cap
BIND 0.00%0.00
PGNXUp 3.62%621.36m
BMYDown 0.02%92.30b
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a biotechnology company, develops novel targeted therapeutics primarily for the treatment of cancer in the United States and Russia. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback